Literature DB >> 2981285

An immunoblot study of neurofilament degradation in situ and during calcium-activated proteolysis.

W W Schlaepfer, C Lee, V M Lee, U J Zimmerman.   

Abstract

The degradation of neurofilament (NF) proteins was examined by immunoblot methods to identify, characterize, and monitor the appearance of immunoreactive breakdown products during the loss of NF triplet proteins. Individual NF proteins and their breakdown products were identified using polyclonal and monoclonal antibodies to NF proteins. NF degradation was compared during calcium-activated proteolysis of isolated rat NF, during an experimental influx of calcium into excised rat spinal nerve roots, and during NF breakdown in transected rat peripheral nerve. These different experimental conditions produced similar patterns of NF fragmentation, including the transient appearance of NF immunobands between Mr 150,000-200,000 and 110,000-120,000 as well as the appearance and accumulation of NF immunobands between Mr 45,000 and 65,000. Most immunoreactive NF fragments remained Triton-insoluble. Low levels of the same immunoreactive fragments were present in control neural tissues, suggesting that calcium-activated proteolysis may be operative in the turnover and/or processing of NF proteins in vivo. Very similar patterns of NF degradation during experimental calcium influxes into different CNS and PNS tissues are indicative of the widespread distribution of calcium-activated NF protease in neural tissues.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981285     DOI: 10.1111/j.1471-4159.1985.tb05442.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

1.  Gene expression of calpains and their specific endogenous inhibitor, calpastatin, in skeletal muscle of fed and fasted rabbits.

Authors:  M A Ilian; N E Forsberg
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

2.  The regulatory role of calmodulin in the proteolysis of individual neurofilament proteins by calpain.

Authors:  G V Johnson; J A Greenwood; A C Costello; J C Troncoso
Journal:  Neurochem Res       Date:  1991-08       Impact factor: 3.996

Review 3.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

4.  Characterization of a shared epitope in cortical Lewy body fibrils and Alzheimer paired helical filaments.

Authors:  M S Pollanen; C Bergeron; L Weyer
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  The effects of autolysis on the structure of chicken calpain II.

Authors:  C Crawford; A C Willis; J Gagnon
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

6.  Effect of BSO and etanidazole on neurofilament degradation in neonatal rat spinal cord cultures.

Authors:  S T Palayoor; E A Bump; D M Saroff; J R Delfs; C Geula; L Menton-Brennan; S J Hurwitz; C N Coleman; M A Stevenson
Journal:  Br J Cancer Suppl       Date:  1996-07

7.  Immunoblot analyses of the relative contributions of cysteine and aspartic proteases to neurofilament breakdown products following experimental brain injury in rats.

Authors:  R M Posmantur; X Zhao; A Kampfl; G L Clifton; R L Hayes
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

Review 8.  Role of calpains in the injury-induced dysfunction and degeneration of the mammalian axon.

Authors:  Marek Ma
Journal:  Neurobiol Dis       Date:  2013-08-19       Impact factor: 5.996

9.  Calpain from rat intestinal epithelial cells: age-dependent dynamics during cell differentiation.

Authors:  M Ibrahim; R K Upreti; A M Kidwai
Journal:  Mol Cell Biochem       Date:  1994-02-09       Impact factor: 3.396

10.  Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection.

Authors:  Hua Shen; Krzysztof L Hyrc; Mark P Goldberg
Journal:  Neurobiol Dis       Date:  2013-07-24       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.